Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07532447) titled 'Metabolomic Characteristics of Patients With Non-small Cell Lung Cancer in Plasma, Tissue and Exhaled Breath Condensate: A Case-control Study' on April 8.

Study Type: Observational

Primary Sponsor: People's Hospital of Xinjiang Uygur Autonomous Region

Condition: Non-small Cell Lung Cancer Benign Pulmonary Nodules

Recruitment Status: Not recruiting

Date of First Enrollment: April 30, 2022

Target Sample Size: 74

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07532447

Disclaimer: Curated by HT Syndication....